Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AQP10 | Q96PS8 | Aquaporin-10 (AQP-10) (Aquaglyceroporin-10) (Small intestine aquaporin) | Metabolic proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediation | 1 | 0.50 | |||
| AQP11 | Q8NBQ7 | Aquaporin-11 (AQP-11) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| AQP4 | P55087 | Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4) | Human disease related genesMetabolic proteinsPredicted membrane proteins | 6 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| ASGR2 | P07307 | Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| ASIC1 | P78348 | Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) | 2 | Heart failurePain | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| ASTRB | Q3KR37 | Protein Aster-B (GRAM domain-containing protein 1B) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| ASTRC | Q8IYS0 | Protein Aster-C (GRAM domain-containing protein 1C) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT10D | Q9P241 | Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D) | EnzymesPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT1A1 | P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1) | Cancer-related genesDisease related genesEnzymes | 10 | Cardiac arrhythmiaChronic obstructive pulmonary diseaseCorneal disease | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| AT2A2 | P16615 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) | Disease related genesEnzymesEssential proteins | 10 | AsthmaHeart failureHypertension | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| AT2B1 | P20020 | Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1) | Disease related genesEnzymesFDA approved drug targets | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| AT2B3 | Q16720 | Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3) | Cancer-related genesDisease related genesEnzymes | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| AT2C2 | O75185 | Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 7.2.2.10) (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2) (SPCA2) | EnzymesFDA approved drug targetsMetabolic proteins | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| AT8A2 | Q9NTI2 | Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2) | Disease related genesEnzymesHuman disease related genes | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT8B1 | O43520 | Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1) | Disease related genesEnzymesHuman disease related genes | 10 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| B3GT2 | O43825 | Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2) | 1 | Metabolism mediation | 1 | 0.50 | ||||
| BMPR2 | Q13873 | Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) | Disease related genesEnzymesFDA approved drug targets | 1 | Joint derangementProstate cancerUrinary system disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| BOC | Q9BWV1 | Brother of CDO (Protein BOC) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| BT2A1 | Q7KYR7 | Butyrophilin subfamily 2 member A1 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| BT3A3 | O00478 | Butyrophilin subfamily 3 member A3 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| C1QR1 | Q9NPY3 | Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR) (C1qR(p)) (C1qRp) (CDw93) (Complement component 1 q subcomponent receptor 1) (Matrix-remodeling-associated protein 4) (CD antigen CD93) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| C99L2 | Q8TCZ2 | CD99 antigen-like protein 2 (MIC2-like protein 1) (CD antigen CD99) | Predicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| CAC1C | Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 24 | Alzheimer diseaseAngina pectorisGenetic cardiac arrhythmia | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| CAC1E | Q15878 | Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II) (BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3) | 24 | Heart failureUnspecific body region injury | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| CAD26 | Q8IXH8 | Cadherin-like protein 26 (Cadherin-like protein VR20) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.50 |